Vail Reese, MD Hot Spots 2018 Saturday, August 18th, 2018 Notes: – History of the term “Herpes” from ancient times to present. – Review of the Human Herpesviruses clinical presentations. – Brief review of Herpesviridae presentations in other species. – Discussion of stigma associated with Herpes Simplex Virus. – Justification for changing name of Herpesviridae. – Examples of names changed for other conditions. – Proposed name change: Habitaviridae. – Process for adding/changing viral names.  References: Reese V, Croley JA, Wagner RF. Countering Creeping Confusion: A Proposal to Re-Name Herpes Virus TAXONOMY. Online Journal of Community and Person-Centered Dermatology Posted January 14th, 2018. http://ojcpcd.com/reese-v/countering-creeping-confusion-a-proposal-to-re-name-herpes-virus-taxonomy/ Ratzen R. Letter: Thoughts about Countering Creeping … Continue reading →

To view the questionnaire we used, click What Matters To Me Questionnaire We are trying to create a tool to help patients communicate with their physicians and other care providers about what really matters to them in their relationships with the health care system. Although one may not always get everything wishes for, this is a chance to share your preferences and values with regards to the healthcare you receive. When answering the questions it may be helpful to think of times you felt that your medical care needs were not met. Please rate choices in the order of importance to you. All information is confidential. No one’s identity will … Continue reading →

Very low-dose isotretinoin in mild to moderate papulopustular rosacea; a retrospective review of 52 patients. ABSTRACT BACKGROUND/OBJECTIVES: Rosacea is a chronic inflammatory disorder that affects up to 10% of the population. Standard treatments include topical azelaic acid and metronidazole or systemic tetracyclines. Isotretinoin has generally been restricted to severe disease, often at a dose of 0.5-1.0 mg/kg/day. METHOD: Retrospective review of open-label isotretinoin (initial dose 20 mg/day, with dose adjustments according to response), in patients with mild to moderate papulopustular rosacea. RESULTS: Altogether 52 patients (33 women), mean age 48 years (range 18-86) were treated with isotretinoin over a 5-year period. All patients were commenced on 20-mg isotretinoin/day which was reduced to 10-20 mg once to five times a week (equivalent to 5 mg/day) … Continue reading →

Case Presentation Metastatic BCC 2018 Hot Spots in Dermatology Presenters: Marianna F. Karewicz, NP Roman W. Glamb, MD Straub Medical Center Download Fyll Presentation:  Metastatic Basal Cell Abstract Basal Cell Carcinoma (BCC) is deemed as one of the most frequent types of skin cancer. Typically, it is regarded as localized in nature and there is a tendency to view the condition as non-malignant because the tumor rarely metastasizes (Habif, 2016). However, what if the condition became aggressive? If left untreated, BCC has the capability to spread through direct extension, destroying normal tissue and large portions of the body; even penetrating the subcutaneous tissue to bone and/or the brain. This case … Continue reading →